The role of mitochondrial genome abundance in Alzheimer's disease
Authors:
Open Access
- 12 October 2022
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (5) , 2069-2083
Abstract
Mitochondrial dysfunction is an early and prominent feature of Alzheimer's disease (AD), with impaired energy metabolism preceding the onset of clinical symptoms. Here we propose an update to the mitochondrial dysfunction hypothesis of AD based on recent results examining the role of mitochondrial genome abundance in AD. In a large post mortem study, we show that lower brain mitochondrial genome abundance is associated with a greater odds of AD neuropathological change and worse cognitive performance. We hypothesize that lower mitochondrial genome abundance impairs mitochondrial function by reducing mitochondrial bioenergetics, thereby impacting neuronal and glial cell function. However, it remains to be determined if mitochondrial dysfunction causes, mediates, or is a by‐product of AD pathogenesis. Additional support for this hypothesis will be generated by linking peripheral blood mitochondrial genome abundance to AD and establishing clinical trials of compounds that upregulate total mitochondrial genome abundance or boost mitochondrial mass.Keywords
All Related Versions
This publication has 68 references indexed in Scilit:
- The Alzheimer's disease mitochondrial cascade hypothesis: Progress and perspectivesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014
- Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigeneticsMitochondrion, 2013
- Updated comprehensive phylogenetic tree of global human mitochondrial DNA variationHuman Mutation, 2008
- Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neuronsProceedings of the National Academy of Sciences, 2008
- Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replicationProceedings of the National Academy of Sciences, 2004
- Correlation of the Clinical Severity of Alzheimer's Disease With an Aberration in Mitochondrial DNA (mtDNA)Journal of Molecular Neuroscience, 2001
- Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer DiseaseJAMA, 1997
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)Neurology, 1991